Clinical Trial

Clinical Investigation Measuring the Long Term Clinical Performance and Safety of Biodentine™ XP in Patients Treated for Coronal Restorative or Endodontic Dental Indications.

Study acronym: BIOD XP
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this present study is to collect additional data for the post-marketing follow-up of Biodentine™ XP and measure long-term (up to 10 years) performance and safety of the biomaterial in all its indications.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-25; most recent amendment 2026-04-30.
Status change: Not Yet Recruiting → Recruiting 2026-04-30
Trial Details
NCT Number NCT06955429
Lead Sponsor Septodont
Collaborators: DOCAPOST, Axonal-Biostatem
Conditions Dental Restoration, Permanent, Dental Restorations, Endodontic Treatment
Enrollment 275 participants
Start Date 2025-10-23
Primary Completion 2032-02-29 (estimated)
Study Completion 2037-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-05-06